| GTO ID | GTC1834 |
| Trial ID | NCT03373097 |
| Disease | Neuroblastoma | Ewing Sarcoma | Osteosarcoma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors |
| Year | 2018 |
| Country | Italy |
| Company sponsor | Bambino Gesù Hospital and Research Institute |
| Other ID(s) | GD2CAR01 |
| Cohort 1 | |||||||||||||
|
|||||||||||||